Appears on
Articles2
Building momentum through the VPAG review
The latest Operational Review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) took place in late December. In this piece, Pinchas Kahtan, ABPI's Head of Commercial Policy, shares the key points discussed and agreed at the meeting, and looks ahead to what's next for 2026.
0
ABPI Blogs and News3mo agoUnderstanding NHS medicines spending in England
This article discusses what the NHS Business Services Authority (BSA) data can tell us about NHS medicine spending and how industry payments shape the true level of NHS spending on medicines.
0
ABPI Blogs and News4d ago